ABSTRACT: Obesity has been increasing significantly in Brazil and worldwide, becoming a major public health issue. Traditional prevention and treatment strategies, including behavioral interventions, ...

Glucagon-like peptide-1 (GLP-1 ... are concerned about an increased risk of aspiration in patients using GLP-1 receptor agonists, owing to their mechanism of action. Unfortunately, whether, and to ...

Incretin receptor agonists (IRAs), primarily composed of glucagon-like peptide-1 receptor agonists ... IRAs have been linked to reductions in LDL-c, TC, TG, and SBP. The mechanisms of action include ...

Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Advertisement Under the Medicaid system ...

The use of glucagon-like peptide 1 (GLP-1) receptor agonists in adults with type 2 diabetes mellitus (T2DM) was not ...

The question of putative mechanisms of action continues to haunt psychopharmacology. Put simply, we know these drugs work, but we have very little idea how. We make guesses based on the ...

New research suggests that it could be possible to separate treatment from hallucinations when developing new drugs based on ...

The Osmo Action 5 Pro stands out from the rest of the action camera market for its battery life. It can shoot well over two hours at 4K resolution and 60 frames per second, which is far and away ...